Bowles Kathryn H, Chittams Jesse, Heil Eric, Topaz Maxim, Rickard Kathy, Bhasker Mrinal, Tanzer Matt, Behta Maryam, Hanlon Alexandra L
Center for Integrative Science in Aging, University of Pennsylvania School of Nursing, 418 Curie Boulevard, Philadelphia, PA, 19104.
Res Nurs Health. 2015 Apr;38(2):102-14. doi: 10.1002/nur.21643. Epub 2015 Jan 25.
In a quasi-experimental study, decision support software was installed in three hospitals to study the ability to scale (spread) its use from one hospital on paper to three hospitals as software, and to examine the effect on 30- and 60-day readmissions. The Discharge Decision Support System (D2S2) software analyzes data collected by nurses on admission with a proprietary risk assessment tool, identifies patients in need of post-acute care, and alerts discharge planners. On six intervention units, with a concurrent comparison group of 76 units, we examined the implementation experience and compared readmission outcomes before and after implementation. The software implementation finished one month ahead of schedule, and the software performed reliably. High-risk patients admitted in the experimental phase after implementation of D2S2 decision support had significantly fewer 30-day readmissions (a decrease from 22.2% to 9.4%). When high- and low-risk patients were analyzed together, D2S2 achieved a 33% relative reduction in 30-day readmissions (13.1 to 8.8%) and sustained a 37% relative reduction at 60 days. The software, available commercially through RightCare Solutions, was adopted by the health system and remains in use after 22 months. The D2S2 risk assessment tool can be installed easily in existing EHR systems. Future research will focus on how the tool influences discharge decision-making and how its accuracy can be improved in specific settings.
在一项准实验研究中,决策支持软件被安装在三家医院,以研究其使用范围从纸质形式在一家医院扩展到作为软件在三家医院推广的能力,并考察对30天和60天再入院率的影响。出院决策支持系统(D2S2)软件使用专有的风险评估工具分析护士在患者入院时收集的数据,识别需要急性后期护理的患者,并向出院计划人员发出警报。在六个干预科室以及由76个科室组成的同期对照组中,我们考察了实施经验,并比较了实施前后的再入院结果。软件实施提前一个月完成,且运行可靠。在实施D2S2决策支持后的实验阶段入院的高危患者30天再入院率显著降低(从22.2%降至9.4%)。当对高危和低危患者一起进行分析时,D2S2使30天再入院率相对降低了33%(从13.1%降至8.8%),并在60天时保持了37%的相对降低率。该软件可通过RightCare Solutions公司进行商业采购,已被医疗系统采用并在22个月后仍在使用。D2S2风险评估工具可以轻松安装到现有的电子健康记录系统中。未来的研究将聚焦于该工具如何影响出院决策,以及在特定环境中如何提高其准确性。